Viewing Study NCT05192304


Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2025-12-26 @ 9:10 PM
Study NCT ID: NCT05192304
Status: UNKNOWN
Last Update Posted: 2022-01-14
First Post: 2021-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia
Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module